BACKGROUND: Most women with histories of gestational diabetes mellitus do not receive a postpartum screening test for type 2 diabetes, even though they are at increased risk. The objective of this study was to identify factors associated with high rates of postpartum glucose screening. METHODS: This cross-sectional analysis assessed characteristics associated with postpartum diabetes screening for patients with gestational diabetes mellitus (GDM)-affected pregnancies self-reported by randomly sampled licensed obstetricians/gynecologists (OBs/GYNs) in Ohio in 2010. RESULTS: Responses were received from 306 OBs/GYNs (56.5% response rate), among whom 69.9% reported frequently (always/most of the time) screening women with GDM-affected pregnancies for abnormal glucose tolerance at the postpartum visit. Compared to infrequent screeners, OBs/GYNs who frequently screen for postpartum glucose tolerance were statistically (p<0.05) more likely to have a clinical protocol addressing postpartum testing (67.2% vs. 26.7%), an electronic reminder system for providers (10.8% vs. 2.2%) and provide reminders to patients (16.4% vs. 4.4%). Frequent screeners were more likely to use recommended fasting blood glucose or 2-hour oral glucose tolerance test (61.8% vs. 34.6%, p<0.001) than infrequent screeners. CONCLUSIONS: Strategies associated with higher postpartum glucose screening for GDM patients included clinical protocols for postpartum testing, electronic medical records to alert providers of the need for testing, and reminders to patients.
BACKGROUND: Most women with histories of gestational diabetes mellitus do not receive a postpartum screening test for type 2 diabetes, even though they are at increased risk. The objective of this study was to identify factors associated with high rates of postpartum glucose screening. METHODS: This cross-sectional analysis assessed characteristics associated with postpartum diabetes screening for patients with gestational diabetes mellitus (GDM)-affected pregnancies self-reported by randomly sampled licensed obstetricians/gynecologists (OBs/GYNs) in Ohio in 2010. RESULTS: Responses were received from 306 OBs/GYNs (56.5% response rate), among whom 69.9% reported frequently (always/most of the time) screening women with GDM-affected pregnancies for abnormal glucose tolerance at the postpartum visit. Compared to infrequent screeners, OBs/GYNs who frequently screen for postpartum glucose tolerance were statistically (p<0.05) more likely to have a clinical protocol addressing postpartum testing (67.2% vs. 26.7%), an electronic reminder system for providers (10.8% vs. 2.2%) and provide reminders to patients (16.4% vs. 4.4%). Frequent screeners were more likely to use recommended fasting blood glucose or 2-hour oral glucose tolerance test (61.8% vs. 34.6%, p<0.001) than infrequent screeners. CONCLUSIONS: Strategies associated with higher postpartum glucose screening for GDM patients included clinical protocols for postpartum testing, electronic medical records to alert providers of the need for testing, and reminders to patients.
Authors: David M Mosen; Adrianne C Feldstein; Nancy Perrin; A Gabriela Rosales; David H Smith; Elizabeth G Liles; Jennifer L Schneider; Jennifer E Lafata; Ronald E Myers; Michael Kositch; Thomas Hickey; Russell E Glasgow Journal: Med Care Date: 2010-07 Impact factor: 2.983
Authors: Boyd E Metzger; Thomas A Buchanan; Donald R Coustan; Alberto de Leiva; David B Dunger; David R Hadden; Moshe Hod; John L Kitzmiller; Siri L Kjos; Jeremy N Oats; David J Pettitt; David A Sacks; Christos Zoupas Journal: Diabetes Care Date: 2007-07 Impact factor: 19.112
Authors: Michelle A Russell; Maureen G Phipps; Courtney L Olson; H Gilbert Welch; Marshall W Carpenter Journal: Obstet Gynecol Date: 2006-12 Impact factor: 7.661
Authors: Steven G Gabbe; Rebecca Pratt Gregory; Michael L Power; Sterling B Williams; Jay Schulkin Journal: Obstet Gynecol Date: 2004-06 Impact factor: 7.661
Authors: Eeva Korpi-Hyövälti; David E Laaksonen; Ursula Schwab; Seppo Heinonen; Leo Niskanen Journal: Int J Endocrinol Date: 2012-03-25 Impact factor: 3.257
Authors: Loren Rodgers; Elizabeth J Conrey; Andrew Wapner; Jean Y Ko; Patricia M Dietz; Reena Oza-Frank Journal: Prev Chronic Dis Date: 2014-12-04 Impact factor: 2.830
Authors: Judith A Bernstein; Lois McCloskey; Christina M Gebel; Ronald E Iverson; Aviva Lee-Parritz Journal: BMJ Open Diabetes Res Care Date: 2016-06-17